Susquehanna International Group
ONCR

Susquehanna International Group’s Oncorus, Inc. ONCR Stock Holding History

Susquehanna International Group’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,000
Closed -$21K – 14499
2022
Q2 		$21K Buy
+17,000
New +$23.1K ﹤0.01% 12360
2022
Q1 		– Sell
-11,900
Closed -$63K – 14333
2021
Q4 		$63K Buy
+11,900
New +$92.1K ﹤0.01% 12438

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Susquehanna International Group's ONCR Position: Q2 2023 in Review

Susquehanna International Group sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 17,525 shares — an estimated $6.03K sold.

Susquehanna International Group first reported a position in ONCR in Q1 2021 and held it in 4 quarters. The position peaked at $489K in Q1 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Susquehanna International Group reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 17,525 Oncorus, Inc. shares in Q2 2023, an estimated $6.03K.
  • Susquehanna International Group first reported a position in Oncorus, Inc. in Q1 2021 and held it in 4 quarters.
  • Susquehanna International Group's Oncorus, Inc. position peaked at $489K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.